Gilead Sciences, Inc. recalls Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets, 30 Tablet Bottles, Rx on
Recalled March 5, 2014 · FDA recall D-1090-2014 · Gilead Sciences
Hazard
Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug. · FDA Class III
Units
39,223 bottles
Sold at
Nationwide including Puerto Rico.
Description
Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.
Product
Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets, 30 Tablet Bottles, Rx only. Manufactured for: Bristol-Myers Squibb & Gilead Sciences, LLC, Foster City, CA 94404. Made in Ireland. NDC 15584-0101-1. Manufactured for: Bristol-Myers-Squibb & Gilead Sciences, LLC, Foster City, CA 94404 Made in Ireland
Manufacturer(s)
Gilead Sciences, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →